UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies

Cancer cell, 2021-10, Vol.39 (10), p.1297-1299

2021

Link zum Volltext

Verfügbarkeit prüfen

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies

Cancer cell, 2021-08, Vol.39 (8), p.1031-1033

2021

Link zum Volltext

Verfügbarkeit prüfen

Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy

Cancer cell, 2017-12, Vol.32 (6), p.748-760.e6

2017

Link zum Volltext

Verfügbarkeit prüfen

Danger ahead: COVID-19 infections after vaccination

Blood, 2022-03, Vol.139 (10), p.1429-1430

2022

Link zum Volltext

Verfügbarkeit prüfen

Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

Clinical cancer research, 2016-02, Vol.22 (4), p.868-876

2016

Link zum Volltext

Verfügbarkeit prüfen

Activation of p53 by the MDM2 inhibitor RG7112 impairs thrombopoiesis

Experimental hematology, 2014-02, Vol.42 (2), p.137-145.e5

2014

Link zum Volltext

Verfügbarkeit prüfen

Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma

Oncotarget, 2015-04, Vol.6 (12), p.10207-10221

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors

Investigational new drugs, 2021-12, Vol.39 (6), p.1587-1597

2021

Link zum Volltext

Verfügbarkeit prüfen

Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies

Blood cancer discovery, 2022-11, Vol.3 (6), p.481

2022

Link zum Volltext

Verfügbarkeit prüfen

C-Terminal p53 Palindromic Tetrapeptide Restores Full Apoptotic Function to Mutant p53 Cancer Cells In Vitro and In Vivo

Biomedicines, 2023-01, Vol.11 (1), p.137

2023

Link zum Volltext

Verfügbarkeit prüfen

Gene Therapy with p14/tBID Induces Selective and Synergistic Apoptosis in Mutant Ras and Mutant p53 Cancer Cells In Vitro and In Vivo

Biomedicines, 2023-01, Vol.11 (2), p.258

2023

Link zum Volltext

Verfügbarkeit prüfen

The advisory dean program: a personalized approach to academic and career advising for medical students

Academic medicine, 2007-07, Vol.82 (7), p.718-722

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase 1/1b Study of RG7388, a Potent MDM2 Antagonist, in Acute Myelogenous Leukemia (AML) Patients (Pts)

Blood, 2014-12, Vol.124 (21), p.116-116

2014

Link zum Volltext

Verfügbarkeit prüfen

Reduction of Paclitaxel-induced Peripheral Neuropathy with Glutamine

Clinical cancer research, 2001-05, Vol.7 (5), p.1192-1197

2001

Link zum Volltext

Verfügbarkeit prüfen

Differentiation of Immortal Cells Inhibits Telomerase Activity

Proceedings of the National Academy of Sciences - PNAS, 1995-12, Vol.92 (26), p.12343-12346

1995

Link zum Volltext

Verfügbarkeit prüfen

Sars-Cov-2 Antibody Levels in Blood Cancer Patients after a Third Sars-Cov-2 “Booster” Vaccination - Observational Data from the LLS National Registry

Blood, 2021-11, Vol.138 (Supplement 1), p.185-185

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract P161: Impaired serological response to SARS-CoV-2 mRNA vaccination in patients with hematologic malignancies

Molecular cancer therapeutics, 2021-12, Vol.20 (12_Supplement), p.P161-P161

2021

Link zum Volltext

Verfügbarkeit prüfen

Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies during the Omicron (B.1.1.529) Surge: Data from the Patient-Reported Leukemia & Lymphoma Society National Registry

Blood, 2022-11, Vol.140 (Supplement 1), p.5250-5251

2022

Link zum Volltext

Verfügbarkeit prüfen

Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide

Molecular cancer therapeutics, 2006-01, Vol.5 (1), p.20-28

2006

Link zum Volltext

Verfügbarkeit prüfen

Update on Recommendations for Assessing Response from the Third International Workshop on Waldenström's Macroglobulinemia

Clinical lymphoma & myeloma, 2006-03, Vol.6 (5), p.380-383

2006

Link zum Volltext

Verfügbarkeit prüfen

Peripheral Blood Stem Cell Mobilization and Harvesting after Fludarabine Therapy for Low-Grade Lymphoma and Chronic Lymphocytic Leukemia

Stem cells and development, 2005-02, Vol.14 (1), p.3-5

2005

Link zum Volltext

Verfügbarkeit prüfen

Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study

Leukemia research, 2021-01, Vol.100, p.106489, Article 106489

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(99)
Buchkapitel
(1)

Sprache

Englisch
(100)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(44)
Humans
(39)
Oncology
(25)
Female
(20)
Male
(17)
Hematology
(14)
Aged
(12)
Adult
(10)
Animals
(10)
Biological And Medical Sciences
(10)
Cell Biology
(9)
Medical Sciences
(8)
Middle Aged
(8)
Proto-Oncogene Proteins C-Mdm2 - Antagonists & Inhibitors
(8)
Mice
(7)
Cancer
(6)
Cancer Research
(6)
Medicine, Research & Experimental
(6)
Research & Experimental Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies

Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2 -amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy

Danger ahead: COVID-19 infections after vaccination

Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

Activation of p53 by the MDM2 inhibitor RG7112 impairs thrombopoiesis

Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma

Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors

Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies

The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia

C-Terminal p53 Palindromic Tetrapeptide Restores Full Apoptotic Function to Mutant p53 Cancer Cells In Vitro and In Vivo

Gene Therapy with p14/tBID Induces Selective and Synergistic Apoptosis in Mutant Ras and Mutant p53 Cancer Cells In Vitro and In Vivo

The advisory dean program: a personalized approach to academic and career advising for medical students

Phase 1/1b Study of RG7388, a Potent MDM2 Antagonist, in Acute Myelogenous Leukemia (AML) Patients (Pts)

Reduction of Paclitaxel-induced Peripheral Neuropathy with Glutamine

Differentiation of Immortal Cells Inhibits Telomerase Activity

Sars-Cov-2 Antibody Levels in Blood Cancer Patients after a Third Sars-Cov-2 “Booster” Vaccination - Observational Data from the LLS National Registry

Abstract P161: Impaired serological response to SARS-CoV-2 mRNA vaccination in patients with hematologic malignancies

Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies during the Omicron (B.1.1.529) Surge: Data from the Patient-Reported Leukemia & Lymphoma Society National Registry

Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide

Update on Recommendations for Assessing Response from the Third International Workshop on Waldenström's Macroglobulinemia

Drug development for major chronic health conditions – aligning with growing public health needs: Proceedings from a multi-stakeholder think tank

Peripheral Blood Stem Cell Mobilization and Harvesting after Fludarabine Therapy for Low-Grade Lymphoma and Chronic Lymphocytic Leukemia

Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study

Suchergebnisse filtern